Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties

Published:2017-04-11 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Luo Cheng,Chen Song,Xu Na,Wang Chi,Sai Wen bo,Zhao Wei,Li Ying chun,Hu Xiao jing,Tian Hong,Gao Xiang dong,Yao Wen bing

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep46347.pdf

Reference52 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5–29, doi: 10.3322/caac.21254 (2015).

2. Ryerson, A. B. et al. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer 122, 1312–1337, doi: 10.1002/cncr.29936 (2016).

3. Incorvati, J. A., Shah, S., Mu, Y. & Lu, J. Targeted therapy for HER2 positive breast cancer. J Hematol Oncol 6, 38, doi: 10.1186/1756-8722-6-38 (2013).

4. Cheang, M. C. et al. Defining breast cancer intrinsic subtypes by quantitative receptor expression. Oncologist 20, 474–482, doi: 10.1634/theoncologist.2014-0372 (2015).

5. Mitri, Z., Constantine, T. & O’Regan, R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract 2012, 743193, doi: 10.1155/2012/743193 (2012).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escherichia coli and Pichia pastoris : microbial cell-factory platform for full-length IgG production;Critical Reviews in Biotechnology;2024-05-26

2. Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade;Frontiers in Immunology;2023-10-31

3. The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy;Frontiers in Immunology;2023-07-27

4. Enhancing pharmacokinetic and pharmacodynamic properties of recombinant therapeutic proteins by manipulation of sialic acid content;Biomedicine & Pharmacotherapy;2023-07

5. Antibody-drug Conjugates for Breast Cancer Treatment;Recent Patents on Anti-Cancer Drug Discovery;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3